NasdaqCM - Nasdaq Real Time Price USD
OSR Holdings, Inc. (OSRHW)
0.0313
-0.0082
(-20.76%)
As of 3:14:03 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Gihyoun Bang | Chief Financial Officer | 47.37k | -- | 1978 |
OSR Holdings, Inc.
10900 NE 4th Street
Suite 2300
Bellevue, WA 98004
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 19
Description
OSR Holdings, Inc. develops a portfolio of therapies and healthcare solutions in the United States, Europe, and South Korea. The company develops immunotherapy products, including VXM01, VXM04, VXM06, VXM08, and VXM10 for cancer treatment; DRT102-sp for the treatment of lumbar stenosis, disc herniaton, and spinal; DRT102-dt for dental augmentation; DRT102-nu for nonunion bone fracture; and DRT101 for osteoarthritis. It also provides medical devices. The company is based in Bellevue, Washington.
Corporate Governance
OSR Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
SRZNW Surrozen, Inc.
0.0224
+38.27%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
ESLAW Estrella Immunopharma, Inc.
0.0885
+5.11%
KMSTF Kadimastem Ltd
5.06
+690.13%
NLSPW NLS Pharmaceutics AG
0.0040
+2.56%
APLMW Apollomics, Inc.
0.0077
0.00%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0300
0.00%
PTIXW Protagenic Therapeutics, Inc.
0.0026
-42.22%
DRMAW Dermata Therapeutics, Inc.
0.0200
-21.88%
ATNFW 180 Life Sciences Corp.
0.0077
+6.94%